Kadcyla (ado-trastuzumab emtansine) - Roche
trastuzumab/pertuzumab (EG13084) - EirGenix
Trodelvy (sacituzumab govitecan-hziy) - Gilead
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
Kisqali (ribociclib) - Novartis
Ibrance (palbociclib) - Pfizer
Perjeta (pertuzumab) - Roche
Keytruda (pembrolizumab) - Merck (MSD)
Lynparza (olaparib) - Merck (MSD), AstraZeneca
http://www.ncbi.nlm.nih.gov/pubmed/41074737
 
Alain Fourquet; Cezara Cheptea; Kim Cao; Pierre Loap; Sofiane Allali; Youlia Kirova
 
Oct 11, 2025
 
Next